title: Listeria monocytogenes sepsis in patients treated with anti-tumor necrosis factor-alpha.
authors.affiliation: Rheumatology Unit, Sheba Medical Center, Tel Hashomer, Israel. nurittw@sheba.health.gov.il
authors.forename: Nurit
authors.initials: N
authors.lastname: Tweezer-Zaks
authors.forename: Eli
authors.initials: E
authors.lastname: Shiloach
authors.forename: Alexander
authors.initials: A
authors.lastname: Spivak
authors.forename: Micha
authors.initials: M
authors.lastname: Rapoport
authors.forename: Ben
authors.initials: B
authors.lastname: Novis
authors.forename: Pnina
authors.initials: P
authors.lastname: Langevitz
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008089:Listeria monocytogenes / Q000302:isolation & purification; D008088:Listeriosis / Q000097:blood / Q000188:drug therapy / Q000276:immunology* / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000097:blood / Q000188:drug therapy / Q000276:immunology* / Q000382:microbiology; D018805:Sepsis / Q000097:blood / Q000188:drug therapy / Q000276:immunology* / Q000382:microbiology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000900:Anti-Bacterial Agents; D014409:Tumor Necrosis Factor-alpha